Jerry Echevarria Mendez, MD
Urology · San Juan, PRNPI 1093165219
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Boston Scientific at 52.5% of the total. Reporting peaked in 2022 at $1,652 and has fallen 90.2% since, to $162 in 2025.
Across 41 payments — averaging $99.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Olympus Latin America, Inc.$1K
- Teleflex LLC$521
- BD$130
- Merck$60
- Pharmaand GmbH$35
- plus $44 from 2 others
What the payments were for
- Travel & lodging$2,26055%
- Food & beverage$1,82245%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $2,144 |
| Olympus Latin America, Inc. | 8 | $1,149 |
| Teleflex LLC | 7 | $521 |
| BD | 1 | $130 |
| Merck | 3 | $60 |
| Pharmaand GmbH | 3 | $35 |
| Johnson & Johnson | 1 | $24 |
| Tolmar, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,082 in reported general payments places this provider in the 65th percentile of 122 urology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tolterodine Tartrate ErTolterodine Tartrate | 91 | $18,230 |
| MyrbetriqMirabegron | 13 | $7,822 |
| Finasteride | 291 | $4,588 |
| Tamsulosin Hcl | 343 | $3,722 |
| Estradiol | 22 | $2,318 |
| Levofloxacin | 100 | $927 |
| Oxybutynin Chloride ErOxybutynin Chloride | 34 | $885 |
| Ketorolac Tromethamine | 63 | $732 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 59 | $579 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $264 |
| Ciprofloxacin Hcl | 21 | $140 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 37 | $119 |
| Cephalexin | 30 | $109 |
| Gentamicin Sulfate | 12 | $53 |
Paid to pharmacies, not to this prescriber.
Other urology in San Juan
- Andres Perez RomanSan Juan$58K
- Rafael Bouet BlasiniSan Juan$55K
- Jose Saavedra-BelaundeSan Juan$45K
- Francisco CapoSan Juan$38K
- Gil NievesSan Juan$30K
- Francois Soto PalouSan Juan$26K
- Pablo Ortiz CerezoSan Juan$20K
- Jorge Rivera HerreraSan Juan$19K
- Eduardo CantoSan Juan$17K
- Hector Cardona DobleSan Juan$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.